Marrone Bio Innovations’ Venerate Biopesticide Named Best New Biological Product at Agrow Awards 2018 in London
November 13 2018 - 8:31AM
Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading
global provider of bio-based pest management and plant health
products, today announced that Agribusiness Intelligence, a leading
media provider for the global crop protection and agricultural
biotechnology industries, awarded Marrone Bio Innovations the Agrow
Awards 2018 - Best New Biological Product award for its Venerate®
bioinsecticide.
Venerate is an advanced microbial biopesticide
based on a new species of bacterium discovered by MBI that produces
several natural compounds, which work together to control a broad
range of chewing and sucking insects and mites, while remaining
non-toxic and low risk to non-target organisms, such as honeybees.
Venerate has multiple modes of action to manage pest populations,
pest resistance, and pesticide residues. It is labeled for and used
on many crops such as grapes, almonds, leafy greens, berries, and
fruiting vegetables and also as a seed treatment on corn, soy,
cotton and wheat.
The Agrow Awards 2018, hosted by Agribusiness
Intelligence, a leading media provider for the global crop
protection and agricultural biotechnology industries, is widely
considered to be a premier industry event, celebrating excellence
across diverse categories which recognize agricultural industry
advancements in technology and innovation within crop protection
and production. Winners are judged by an independent panel of
industry experts. To be eligible for the awards, products were
required to be formulated in a way that is acceptable to users and
distributors, while also providing the ability to forge a path in a
market dominated by synthetic chemicals.
“Venerate biopesticide joins our Regalia
biofungicide, Grandevo bioinsecticide, and Majestene bionematicide
as the winner of the prestigious Agrow Award for the Best New
Biological Product,” said Pam Marrone, CEO of Marrone Bio
Innovations. “It is truly an honor to add yet another award for our
innovative portfolio of biological products. This recognition
further strengthens our position as a thought leader within the
rapidly growing biological crop protection industry. I look forward
to providing our shareholders with further updates on our
cutting-edge product pipeline as appropriate,” concluded
Marrone.
About Marrone Bio
InnovationsBIO WITH
BITE.Marrone Bio Innovations, Inc. (NASDAQ: MBII) strives
to lead the movement to more sustainable world through the
discovery, development and sale of innovative biological products
for crop protection, plant health and waterway systems treatment.
MBI has screened over 18,000 microorganisms and 350 plant extracts,
leveraging its in-depth knowledge of plant and soil microbiomes
enhanced by advanced molecular technologies to rapidly develop
seven effective and environmentally responsible pest management
products to help customers operate more sustainably while uniquely
improving plant health and increasing crop yields. Supported by a
robust portfolio of over 400 issued and pending patents around its
superior natural product chemistry, MBI’s currently available
commercial products are Regalia®, Grandevo®, Venerate®, Majestene®,
Haven® Stargus® and Amplitude™, Zelto® and Zequanox®.
Marrone Bio Innovations is dedicated to
pioneering smart biopesticide solutions that support a better
tomorrow for both farmers, turf managers and consumers around the
globe. For more information, please visit www.marronebio.com.
Marrone Bio Innovations Forward Looking
StatementsThis press release contains forward-looking
statements that involve substantial risks and uncertainties. All
statements, other than statements of historical facts, included in
this press release regarding strategy, future operations and plans,
including assumptions underlying such statements, are
forward-looking statements, and should not be relied upon as
representing MBI’s views as of any subsequent date. Examples of
such statements include the potential above named relationship to
drive sales, provide market projections, and realize the potential
benefits of our products. Such forward-looking statements are based
on information available to the Company as of the date of this
release and involve a number of risks and uncertainties, some
beyond the Company’s control, that could cause actual results to
differ materially from those anticipated by these forward-looking
statements, including weather, regulatory and other factors
affecting demand for the MBI’s products, any difficulty in
marketing MBI’s products in its target markets, competition in the
market for pest management products, lack of understanding of
bio-based pest management products by customers and growers.
Additional information that could lead to material changes in MBI’s
performance is contained in its filings with the SEC. MBI is under
no obligation to, and expressly disclaims any responsibility to,
update or alter forward-looking statements contained in this
release, whether as a result of current information, future events
or otherwise.
Marrone Bio Innovations Contacts: Pam Marrone,
CEO and Founder Telephone: +1 (530) 750-2800 Email:
Info@marronebio.com
MBI Trade Public Relations:Alicia
GillmanMarketing CommunicationsMarrone Bio Innovations Office:
480-889-4219agillman@marronebio.com
MBI Investor Relations: Greg Falesnik Managing
Director MZ Group – MZ North America Main: 949-385-6449
MBII@mzgroup.us www.mzgroup.us
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Mar 2024 to Apr 2024
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Apr 2023 to Apr 2024